ID: ALA1630008

Max Phase: Preclinical

Molecular Formula: C12H16O3

Molecular Weight: 208.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)=CC(O)C#CC#C[C@@H](O)[C@H](C)O

Standard InChI:  InChI=1S/C12H16O3/c1-9(2)8-11(14)6-4-5-7-12(15)10(3)13/h8,10-15H,1-3H3/t10-,11?,12+/m0/s1

Standard InChI Key:  OKPRDFLKKLSGAZ-ASKATJPDSA-N

Associated Targets(non-human)

Quinone oxidoreductase 288 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 208.26Molecular Weight (Monoisotopic): 208.1099AlogP: 0.06#Rotatable Bonds: 2
Polar Surface Area: 60.69Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.40CX Basic pKa: CX LogP: 0.95CX LogD: 0.95
Aromatic Rings: 0Heavy Atoms: 15QED Weighted: 0.44Np Likeness Score: 2.39

References

1. Shin D, Yang JE, Lee SB, Nho CW..  (2010)  SAR studies of gymnasterkoreayne derivatives with cancer chemopreventive activities.,  20  (24): [PMID:21050753] [10.1016/j.bmcl.2010.07.066]

Source